These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2070484)

  • 1. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
    Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.
    Yamazaki H; Inui Y; Yun CH; Guengerich FP; Shimada T
    Carcinogenesis; 1992 Oct; 13(10):1789-94. PubMed ID: 1423839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
    Jalas JR; Ding X; Murphy SE
    Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.
    Tiano HF; Wang RL; Hosokawa M; Crespi C; Tindall KR; Langenbach R
    Carcinogenesis; 1994 Dec; 15(12):2859-66. PubMed ID: 8001247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3.
    Crespi CL; Penman BW; Steimel DT; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1991 Feb; 12(2):355-9. PubMed ID: 1899812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.
    Penman BW; Reece J; Smith T; Yang CS; Gelboin HV; Gonzalez FJ; Crespi CL
    Pharmacogenetics; 1993 Feb; 3(1):28-39. PubMed ID: 8485585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.
    Smith TJ; Guo Z; Gonzalez FJ; Guengerich FP; Stoner GD; Yang CS
    Cancer Res; 1992 Apr; 52(7):1757-63. PubMed ID: 1312898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative metabolism of the tobacco-related carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'- nitrosonornicotine in human hepatic microsomes.
    Staretz ME; Murphy SE; Patten CJ; Nunes MG; Koehl W; Amin S; Koenig LA; Guengerich FP; Hecht SS
    Drug Metab Dispos; 1997 Feb; 25(2):154-62. PubMed ID: 9029045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Tiano HF; Hosokawa M; Chulada PC; Smith PB; Wang RL; Gonzalez FJ; Crespi CL; Langenbach R
    Carcinogenesis; 1993 Jul; 14(7):1421-7. PubMed ID: 8330360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Environ Mol Mutagen; 2001; 38(4):339-46. PubMed ID: 11774366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes.
    Abdel-Rahman SZ; Salama SA; Au WW; Hamada FA
    Pharmacogenetics; 2000 Apr; 10(3):239-49. PubMed ID: 10803680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolism.
    Gelboin HV; Krausz KW; Shou M; Gonzalez FJ; Yang TJ
    Pharmacogenetics; 1997 Dec; 7(6):469-77. PubMed ID: 9429232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Nitrosamide Formation in the Cytochrome P450-Mediated Metabolism of Tobacco-Specific Nitrosamines.
    Carlson ES; Upadhyaya P; Hecht SS
    Chem Res Toxicol; 2016 Dec; 29(12):2194-2205. PubMed ID: 27989137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for metabolic activation of N'-nitrosonornicotine and N-nitrosobenzylmethylamine by a rat nasal coumarin hydroxylase.
    Patten CJ; Peterson LA; Murphy SE
    Drug Metab Dispos; 1998 Feb; 26(2):177-80. PubMed ID: 9456305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
    Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T
    Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue.
    Murphy SE; Heiblum R
    Carcinogenesis; 1990 Sep; 11(9):1663-6. PubMed ID: 2205411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes.
    Collazo NR; Sultatos LG
    Biochem Pharmacol; 1995 Nov; 50(11):1933-41. PubMed ID: 8615875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.